Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on January 26th, 2019 by admin in Pharma R&D
The U.S. government shutdown dragged on past the one-month mark, creating financial panic for many government workers and resulting in a ripple of negative affects across the country. Continue reading “Government Shutdown Could Have Lasting Impact on Scientific Research” »
Posted on January 17th, 2019 by Xuanyan Xu in Pharma R&D
The partial shutdown of the U.S. government, which began just before the Christmas holiday, has been especially terrible for hundreds of thousands of federal employees who are either furloughed or working without pay. Continue reading “Government Shutdown Means New Drugs May Have to Wait – But Safety Monitoring Will Continue” »
Posted on January 15th, 2019 by Xuanyan Xu in Pharma R&D
In the pharmaceutical industry, safety protocols are rigorous. Clinical trials, a lengthy and intense part of the drug development process, are deemed absolutely crucial to ensuring the safety and efficacy of new drugs and therapies. There are also many regulations designed to make certain that high standards are maintained during the various trial phases.